| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |